¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö : 2020-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö : 2020-09-03
±³À°ÀÏÀÚ : 2020-09-03
±³À°Àå¼Ò : Àü³²´ëÇб³º´¿ø ¸íÇд밭´ç  
±³À°ÁÖÁ¦ : 2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : È£³² Áöȸ  
´ã´çÀÚ : ±è⼺
¿¬¶ôó : 02-3486-8736  
À̸ÞÀÏ : laminion@hanmail.net      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-03 ¸íÇд밭´ç 15:30~15:50 µî·Ï ¹× È£³²Áöȸ ȸÀå Àλ砠±è¼ö¿Ï(È£³²ÁöȸÀå) 
±âŸ 09-03 ¸íÇд밭´ç 15:50~16:00 ´ëÇѽÅÀåÇÐȸ ÀÌ»çÀå Àλ砠¾çö¿ì(´ëÇѽÅÀåÇÐȸ ÀÌ»çÀå) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 16:00~16:25 A severe case of tenofovir-associated acute kidney injury requring hemodialysis in a patient with chronic B hepatitis  Á¶¾Æ¿µ(ÀüÁÖ¿¹¼öº´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 16:25~16:50 Xanthogranulomatous osteomyelitis of chest wall in a kidney transplantation patient  ÃÖÁ¾ÀÎ(Á¶¼±´ëÇб³º´¿ø) 
Åä·Ð 09-03 ¸íÇд밭´ç 16:50~17:00 ÆгÎÅäÀÇ(ÁÖÁ¦: Interesting cases of kidney disease)  À̽Ä(ÀüºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 17:00~17:25 ANCA associated vasculitides in a patient with positive serologic test for Hantan virus  ±èÇü¿Ï(ÀüºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 17:25~17:50 A 2-year study on the combination therapy of angiotensin II receptor blocker and midrine for proteinuria reduction in patients with hypotension or normal blood pressure  °­Èñ¸²(¿ø±¤´ëÇб³º´¿ø) 
Åä·Ð 09-03 ¸íÇд밭´ç 17:50~18:00 ÆгÎÅäÀÇ(ÁÖÁ¦: Hot issues of management of kideny disease)  ¸¶¼º±Ç(Àü³²´ëÇб³º´¿ø) 
±âŸ 09-03 ¸íÇд밭´ç 18:00~18:10 Coffee Break & Photo  () 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 18:10~18:35 Impact of obesity on the quality of life in patients with CKD  ¼­»óÇå(Àü³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 18:35~19:00 God committee  À̱¤¿µ(ÀüÁÖ¿¹¼öº´¿ø) 
Åä·Ð 09-03 ¸íÇд밭´ç 19:00~19:10 ÆгÎÅäÀÇ(ÁÖÁ¦: Emerging problems of ethical conflict)  ¾È¼±È£(¿ø±¤´ëÇб³º´¿ø) 
±âŸ 09-03 ¸íÇд밭´ç 19:10~19:20 Æóȸ  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö : 2020-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀºÆò±¸ÀÇ»çȸ Á¦2Â÷¿¬¼ö±³À°(Àü¸³¼±ºñ´ëÁõ, °ú¹Î¼º¹æ±¤) : 2020-09-03
´ÙÀ½±Û ÇѾç´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú ¿Ü·¡¿¡¼­ ½ÃÇàÇÒ ¼ö ÀÖ´Â ºñ°ú °ü·Ã ÀçÈ° Ä¡·á : 2020-09-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
354 ºÎ»ê 2018 ´ëÇѾȰúÀÇ»çȸ 5Â÷ ½ÉÆ÷Áö¿ò : 2018-09-08 0 721 2018-08-08
353 ºÎ»ê ´ëÇÑôÃß¿Ü°úÇÐȸ ºÎ¿ï°æ ´ë±¸ÇÕµ¿ ôÃßÁöȸ ¼¼¹Ì³ª : 2018-09-08 0 577 2018-08-08
352 ±¤ÁÖ ´ëÇÑôÃß¿Ü°úÇÐȸ 2018 ±¤ÁÖ±¹Á¦Ã´Ãß½ÉÆ÷Áö¿ò : 2018-09-08 0 324 2018-08-08
351 ÃæºÏ Á¦14Â÷ ´ëÀüÃæû¼Ò¾Æ½Å°æÁöȸ ½ÉÆ÷Áö¾ö : 2018-09-08 0 731 2018-08-08
350 ¼­¿ï 2018³â ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2018-09-07 0 729 2018-08-08
349 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú ±Ý¿äÁý´ãȸ : 2018-09-07 0 450 2018-08-08
348 ºÎ»ê ÁÁÀº°­¾Èº´¿ø Áø·á½Ç¿¡¼­ ÈçÈ÷ º¸´Â Áõ»óÀÇ Á¢±Ù°ú Ä¡·á : 2018-09-06 0 606 2018-08-08
347 ºÎ»ê ´ëÇѺñ´¢±â°úÇÐȸ ¼Ò¾Æºñ´¢ÀÇÇÐ ¹× ³²¼ºÀÇÇÐ : 2018-09-06 0 843 2018-08-08
346 ±¤ÁÖ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Á¦281Â÷ Àü³²Áöȸ Áý´ãȸ : 2018-09-06 0 378 2018-08-08
345 ÀüºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ÀÎÁöÁßÀçÄ¡·áÀÇ ½ÇÁ¦¿Í Àü¸Á : 2018-09-04 0 549 2018-08-08
344 ºÎ»ê ºÎ¿ï°æ³»ºÐºñ´ë»çÇÐȸ 9¿ù Á¤±âÁý´ãȸ : 2018-09-04 0 496 2018-08-08
343 ¼­¿ï Á¦42ȸ ÇѸ²´ëÇб³°­³²¼º½Éº´¿ø ¾È°ú Áý´ãȸ : 2018-09-03 0 868 2018-08-08
342 ¼­¿ï ¼øõÇâ´ëÇм­¿ïº´¿ø Á¦42ȸ º¹ºÎÃÊÀ½ÆÄ ¹× ³»½Ã°æÃÊÀ½ÆÄ Áø´Ü ¿öÅ©¼ó : 2018-09-02 0 945 2018-08-08
341 ºÎ»ê Á¦21ȸ ´ëÇѳ»°úÇÐȸ ºÎ»ê°æ³²Áöȸ ¿¬¼ö°­Á : 2018-09-02 0 858 2018-08-08
340 ¼­¿ï 2018 ¼Ò¾Æ³»ºÐºñÇÐȸ ¿¬¼ö°­Á : 2018-09-02 0 1,191 2018-08-08
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷